Pharmacology for Obesity Management Flashcards

(29 cards)

1
Q

Why use pharmacology for management? ( 3)

A
  1. improvements in obesity related comorbidities
  2. behaviour changes alone only target 3-5% weight loss, which is not often sustained over long term
  3. pharmacology can facilitate weight management & optimize health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

medications approved in Canada (4) + their average weight loss % in one year

A
  1. Orlistat (-10.2%= 4% BF lost)
  2. Liraglutide (-8.6%= 6% BF lost)
  3. naltrexone/bupropion (-6.1%=5% BF lost)
  4. semaglutide (-14.9%= 12% BF lost)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how medication acts on the body (4)

A
  1. Acts of the hypothalamus
  2. slows stomach emptying (CHO absorption is prolonged)
  3. reduces glucose production in the liver & increases uptake in sk. muscle
  4. raises insulin & lowers glucagon secretion after eating (results in improved insulin sensitivity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the goal of treatment with medication?

A

To decrease the fat mass set point & re-regulate physiology. As set point decreases/resets so does weight loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Many medications work in the brain through neural mechanisms, which medication does not ?

A

Orlistat. And it does not impact the set point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors that drive up set points (environmental & genetic)

A
  1. various environmental factors
    -diet
    -unhealthy muscle
    -sleep deprivation
    -distruped carcadian rhythm
    -sed. behaviour
    -weight gain inducinh medications used to treat other diseases
  2. Genetic factors
    -hormones signals to the brain to let it know our energy state
    -body determines what we eat, how much, when & what we crave.
    -The brain determines & regulates the body fat mass set point
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical considerations with pharmacology treatments

A

-it is intended to be long term & response to treatment will vary by individual
-identify individual goals of therapy prior to initiating
-set reasonable expectations & time required to see benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

targets of treatment (5)

A

-weight loss
-improvement in health parameters not soley weight reduction
-weight maintenence in health parameters
-control cravings
-improvement in quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

other considerations for the use of pharmacology (9)

A
  1. goals of therapy
  2. patient values & preferences
  3. patient co morbidities
  4. mechanism of action
  5. side effects/tolerability
  6. safety
  7. existing medications
  8. mode & frequency of administration
  9. cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

common side effects: semaglutide

A

nausea, vomitting, diarrhea & constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

common side effects: Liraglutide

A

nausea, vomitting, diarrhea & constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

common side effects: Naltrexone/bupropion

A

nausea, vomitting, diarrhea & constipation, headache, drymouth, dizzy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

common side effects: Orlistat

A

loose, oily stools & flatus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

semaglutide as a treatment (4)

A
  1. an effective approach to treating obesity
  2. focus should be on improving health parameters > soley weight reduction
  3. intended as part of a long term strategy
  4. demonstrates higher efficacy than any other previously approved anti-obesity med. Effects on lean body mass have not been studied
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is bariatric surgery

A

gastrointestinal surgical intervention conducted to produce sustainable weight loss

  • currently the best theraputic modality that can truely claim to produce sustainable weight loss
17
Q

who qualifies for bariatric surgey?

A
  1. BMI >40 (class 3)
  2. BMI >35 (class 2) & severe weight related co-morbidities
  3. BMI >30 (class 1) if coupled w/ T2D may be considered
18
Q

other eligabilities for bariatric surgery (4)

A

-pre op testing & consult
- mentally & emotionally prepared
-support system in place
-committed to life long adherence

19
Q

eligabilities for anti obesity medications

A
  1. BMI >30
    OR
  2. BMI >27 with comorbidities
20
Q

what is gastric sleeve surgery

A

-restrictive intervention
-longitudinal resection of the stomach. Takes out 85% of stomach.
-reduces functional capacity of the stomach & eliminates the ghrelin rich gastric fluids
-results in 33% weight loss per year
-small capacity/resistant to stretching

21
Q

what is Roux en Y gastric bypass

A

-combination intervention
-Ingested food by passes 95% of the stomach
-entire duodenum & portion of jejunum
-limited nutrient absorption, have to take supplements (B Vit & iron) for the rest of your life
-Probably not ideal if you are looking to get pregnant
-low ability to cheat (drink their calories)
-good surgery for food addictions due to malabsorption of nutrients

22
Q

what is Biliopancreatic Diversion surgery

A

-combination intervention
-less common & more risky. Prone to serious malnutrition & deficiences
-stomach & small intestine surgically reduced so nutrients absorbed only in50cm common limb

23
Q

gastric bypass: pro (6)

A

-covered by MSP
-average weight loss is 75% of excess weight
-weigt loss occurs rapidly in first 12 months
-96% of associated health conditions are improved
-early & late complication rates are low
-patient returns to eating normal but at low quantities

24
Q

Gastric bypass: cons (5)

A

-poor absorption of iron & calcium due to by passed duodenum
-no iron/calcium can lead to anemia
-vitamin B12 deficiency may occur
-Women should be careful since they are already at risk for osteoporosis
-Dumping syndrome: due to rapid emptying of the stomach into small intestine (triggered with too much sugar/food)
-ulcers/bleeding may occur if poor vision while in surgery

25
typical patient for bypass surgery
women in her 40's who has obesity & other conditions
26
risks of bariatric surgery (3)
-complications & readmission rates have decreased and are rare -complications are less than hip surgery -readmission rates are similar for surgical patients all over canada
27
non fatal (general) complications with bariatric surgery (9)
-dumping syndrome -vitamin/mineral deficiency -vomitting/nausea -staple line fracture -infection -stenosis/bowel obstruction -ulceration -bleeding -splenic surgery
28
benefits of bypass surgery
-reduces onset diabetes -remission of existing diabetes -lower mortality rate
29
what to consider when thinking about bypass surgery? (5)
1. accessibility 2. expectations 3. psychological impact? (marriage, relationships can be neg. impacted) 4. post operative plastic surgery (remove extra skin) 5. side effects (expected/unexpected)